Instruments used in measuring symptoms, health status and quality of life in hypothyroidism: A systematic qualitative review

Clinical Endocrinology

Volumn 63, Issue 6, 2005, Pages 617-624

  Razvi, Salman ^a   McMillan, Carolyn V ^b   Weaver, Jolanta U ^a,c  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILLEWICZ INDEX; CHRONIC THYROID QUESTIONNAIRE; CLINICAL PRACTICE; COLORADO HEALTH FAIR THYROID DISEASE SYMPTOM SURVEY; GHQ INSTRUMENT; HADS QUESTIONNAIRE; HEALTH STATUS; HUMAN; HYPOTHYROID CLINICAL SCORING SYSTEM; HYPOTHYROIDISM; INSTRUMENTATION; INTERMETHOD COMPARISON; MEASUREMENT; NHP INSTRUMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SCORING SYSTEM; SF 36 INSTRUMENT; SYMPTOMATOLOGY; THYROID SYMPTOM QUESTIONNAIRE; UNDERACTIVE THYROID DEPENDENT QUALITY OF LIFE QUESTIONNAIRE; ZULEWSKI INDEX;

BIOLOGICAL MARKERS; HEALTH STATUS INDICATORS; HUMANS; HYPOTHYROIDISM; QUALITY OF LIFE; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY;

EID: 28844431502     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02381.x     Document Type: Review

References (77)

1. Vanderpump, M.P.J. & Tunbridge, W.M.G. (1996) The epidemiology of thyroid disease. In: L.E. Braverman, R.D. Utiger eds. The Thyroid, 9th edn. Lippincott-Raven, Philadelphia, 474-482.
2. Ladenson, P.W., Singer, P.A., Ain, K.B., Bagchi, N., Bigos, S.T., Levy, E.G., Smith, S.A., Daniels, G.H. & Cohen, H.D. (2000) American Thyroid Association guidelines for detection of thyroid dysfunction. Archives of Internal Medicine, 160, 1573-1575.
3. Canaris, G.J., Steiner, J.F. & Ridgway, E.G. (1997) Do traditional symptoms of hypothyroidism correlate with biochemical disease? Journal of General Internal Medicine, 12, 544-550.
4. Spencer, C.A., Takeuchi, M. & Kazarosyan, M. (1996) Current status and performance goals for serum thyrotropin (TSH) assays. Clinical Chemistry, 42, 140-145.
5. Surks, M.I., Ortiz, E., Daniels, G.H., Sawin, C.T., Col, N.F., Cobin, R.H., Franklyn, J.A., Hershman, J.M., Burman, K.D., Denke, M.A., Gorman, C., Cooper, R.S. & Weissman, N.J. (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. Journal of the American Medical Association, 291, 228-238.
6. Cooper, D.S. (2001) Clinical practice. Subclinical hypothyroidism. New England Journal of Medicine, 345, 260-265.
7. Jaeschke, R., Guyatt, G., Cook, D., Harper, S. & Gerstein, H.C. (1994) Spectrum of quality of life impairment in hypothyroidism. Quality of Life Research, 3, 323-327.
8. Roberts, N.D. (1996) Psychological problems in thyroid disease. British Thyroid Foundation Newsletter, 18.
9. Saravanan, P., Chau, W.F., Roberts, N., Vedhara, K., Greenwood, R. & Dayan, C.M. (2002) Psychological well-being in patients on 'adequate' doses of 1-thyroxine: results of a large, controlled community-based questionnaire study. Clinical Endocrinology, 57, 577-585.
10. Kaplan, M.M., Sarne, D.H. & Schneider, A.B. (2003) In search of the impossible dream? Thyroid hormone replacement therapy that treats all symptoms in all hypothyroid patients. Journal of Clinical Endocrinology and Metabolism, 88, 4540-4542.
11. Walsh, J.P. (2002) Dissatisfaction with thyroxine therapy - could the patients be right? Current Opinion in Pharmacology, 2, 717-722.
12. Cooper, D.S. (1991) Subclinical hypothyroidism. In: E.L. Mazzferri ed. Advances in Endocrinology and Metabolism. Mosby-Year Book, St Louis, Baltimore, 77-88.
13. Ellwood, P.M. (1988) Shattuck lecture - outcomes management. A technology of patient experience. New England Journal of Medicine, 318, 1549-1556.
14. Guyatt, G.H., Naylor, C.D., Juniper, E., Heyland, D.K., Jaeschke, R. & Cook, D.J. (1997) Users' guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group. Journal of the American Medical Association, 277, 1232-1237.
15. WHOQOL Group (1995) The World Health Organization Quality of Life Assessment (WHOQOL) position paper from the WHO. Social Science and Medicine, 41, 1043-1049.
16. Joyce, C.R., ed. (1994) Requirements for the Assessment of Individual Quality of Life. Harwood Academic, Chur, Switzerland.
17. Guyatt, G.H., Veldhuyzen Van Zanten, S.J., Feeny, D.H. & Patrick, D.L. (1989) Measuring quality of life in clinical trials: a taxonomy and review. Canadian Medical Association Journal, 140, 1441-1448.
18. Guyatt, G.H., Bombardier, C. & Tugwell, P.X. (1986) Measuring disease-specific quality of life in clinical trials. Canadian Medical Association Journal, 134, 889-895.
19. McNeil, B.J., Weichselbaum, R. & Pauker, S.G. (1981) Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. New England Journal of Medicine, 305, 982-987.
20. Smith, K.W., Avis, N.E. & Assmann, S.F. (1999) Distinguishing between quality of life and health status in quality of life research: a meta-analysis. Quality of Life Research, 8, 447-459.
21. Bradley, C. (2001) Importance of differentiating health status from quality of life. Lancet, 357, 7-8.
22. Leplege, A. & Hunt, S. (1997) The problem of quality of life in medicine. Journal of the American Medical Association, 278, 47-50.
23. Ware, J.E., Kosinski, M. & Gandek, B. (1993, 2000) SF-36 Health Survey: Manual and Interpretation Guide. QualityMetric Incorporated, Lincoln, RI.
24. Hunt, S.M., McEwen, J. & McKenna, S.P. (1985) Measuring health status: a new tool for clinicians and epidemiologists. Journal of the Royal College of General Practitioners, 35, 185-188.
25. Goldberg, D. & Williams, P. (1988) A User's Guide to the General Health Questionnaire. NFER-Nelson, Windsor, UK.
26. Herrmann, C. (1997) International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. Journal of Psychosomatic Research, 42, 17-41.
27. Garratt, A.M., Ruta, D.A., Abdalla, M.I., Buckingham, J.K. & Russell, I.T. (1993) The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? British Medical Journal, 306, 1440-1444.
28. Jenkinson, C. & McGee, H. (1997) Patient-assessed Outcomes: Measuring Health Status and Quality of Life. Open University Press, Buckingham.
29. Jenkinson, C., Stewart-Brown, S., Petersen, S. & Paice, C. (1999) Assessment of the SF-36 version 2 in the United Kingdom. Journal of Epidemiology and Community Health, 53, 46-50.
30. Hayes, V., Morris, J., Wolfe, C. & Morgan, M. (1995) The SF-36 health survey questionnaire: is it suitable for use with older adults? Age and Ageing, 24, 120-125.
31. Bianchi, G.P., Zaccheroni, V., Solaroli, E., Vescini, F., Cerutti, R., Zoli, M. & Marchesini, G. (2004) Health-related quality of life in patients with thyroid disorders. Quality Life Research, 13, 45-54.
32. Pollock, M.A., Sturrock, A., Marshall, K., Davidson, K.M., Kelly, C.J., McMahon, A.D. & McLaren, E.H. (2001) Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial. British Medical Journal, 323, 891-895.
33. Botella-Carretero, J.I., Galan, J.M., Caballero, C., Sancho, J. & Escobar-Morreale, H.F. (2003) Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocrine-Related Cancer, 10, 601-610.
34. Golger, A., Fridman, T.R., Eski, S., Witterick, I.J., Freeman, J.L. & Walfish, P.G. (2003) Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma. Journal of Endocrinological Investigation, 26, 1023-1031.
35. Crevenna, R., Zettinig, G., Keilani, M., Posch, M., Schmidinger, M., Pirich, C., Nuhr, M., Wolzt, M., Quittan, M., Fialka-Moser, V. & Dudczak, R. (2003) Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy. Supportive Care in Cancer, 11, 597-603.
36. Walsh, J.P., Shiels, L., Lim, E.M., Bhagat, C.I., Ward, L.C., Stuckey, B.G., Dhaliwal, S.S., Chew, G.T., Bhagat, M.C. & Cussons, A.J. (2003) Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. Journal of Clinical Endocrinology and Metabolism, 88, 4543-4550.
37. Sawka, A.M., Gerstein, H.C., Marriott, M.J., MacQueen, G.M. & Joffe, R.T. (2003) Does a combination regimen of thyroxine (T4) and 3,5,3′-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. Journal of Clinical Endocrinology and Metabolism, 88, 4551-4555.
38. Escobar-Morreale, H.F., Botella-Carretero, J.I., Gomez-Bueno, M., Galan, J.M., Barrios, V. & Sancho, J. (2005) Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Annals of Internal Medicine, 142, 412-424.
39. O'Brien, B.J., Banner, N.R., Gibson, S. & Yacoub, M.H. (1988) The Nottingham Health Profile as a measure of quality of life following combined heart and lung transplantation. Journal of Epidemiology and Community Health, 42, 232-234.
40. Jenkinson, C., Fitzpatrick, R. & Argyle, M. (1988) The Nottingham Health Profile: an analysis of its sensitivity in differentiating illness groups. Social Science and Medicine, 27, 1411-1414.
41. de Lame, P.A., Droussin, A.M., Thomson, M., Verhaest, L. & Wallace, S. (1989) The effects of enalapril on hypertension and quality of life. A large multicenter study in Belgium. Acta Cardiologica, 44, 289-302.
42. Wiklund, I., Romanus, B. & Hunt, S.M. (1988) Self-assessed disability in patients with arthrosis of the hip joint. Reliability of the Swedish version of the Nottingham Health Profile. International Disability Studies, 10, 159-163.
43. Wilkin, D., Hallam, L. & Doggett, M. (1992) Measures of Need and Outcome for Primary Care. Oxford University Press, Oxford.
44. Kind, P. & Carr-Hill, R. (1987) The Nottingham Health Profile: a useful tool for epidemiologists? Social Science and Medicine, 25, 905-910.
45. Brazier, J.E., Harper, R., Jones, N.M., O'Cathain, A., Thomas, K.J., Usherwood, T. & Westlake, L. (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. British Medical Journal, 305, 160-164.
46. Goldberg, D.P., Rickels, K., Downing, R. & Hesbacher, P. (1976) A comparison of two psychiatric screening tests. British Journal of Psychiatry, 129, 61-67.
47. Kent, G.N., Stuckey, B.C., Allen, J.R., Lambert, T. & Gee, V. (1999) Postpartum thyroid dysfunction: clinical assessment and relationship to psychiatric affective morbidity. Clinical Endocrinology, 51, 429-438.
48. Larisch, R., Kley, K., Nikolaus, S., Sitte, W., Franz, M., Hautzel, H., Tress, W. & Muller, H.W. (2004) Depression and anxiety in different thyroid function states. Hormone and Metabolic Research, 36, 650-653.
49. Saravanan, P., Simmons, D.J., Greenwood, R., Peters, T.J. & Dayan, C.M. (2005) Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial. Journal of Clinical Endocrinology and Metabolism, 90, 805-812.
50. Kong, W.M., Sheikh, M.H., Lumb, P.J., Freedman, D.B., Crook, M., Dore, C.J. & Finer, N. (2002) A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. American Journal of Medicine, 112, 348-354.
51. Petersen, K., Bengtsson, C., Lapidus, L., Lindstedt, G. & Nystrom, E. (1990) Morbidity, mortality, and quality of life for patients treated with levothyroxine. Archives of Internal Medicine, 150, 2077-2081.
52. Terwee, C.B., Gerding, M.N., Dekker, F.W., Prummel, M.F. & Wiersinga, W.M. (1998) Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. British Journal of Ophthalmology, 82, 773-779.
53. Jaeschke, R., Guyatt, G., Gerstein, H., Patterson, C., Molloy, W., Cook, D., Harper, S., Griffith, L. & Carbotte, R. (1996) Does treatment with 1-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? Journal of General Internal Medicine, 11, 744-749.
54. Goldmann, D.R. (1996) Subclinical hypothyroidism revisited. When is not enough really not enough? Journal of General Internal Medicine, 11, 771-773.
55. Clyde, P.W., Harari, A.E., Getka, E.J. & Shakir, K.M. (2003) Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. Journal of the American Medical Association, 290, 2952-2958.
56. McMillan, C.V., Bradley, C., Woodcock, A., Razvi, S. & Weaver, J.U. (2004) Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism. Thyroid, 14, 916-925.
57. Bradley, C., Todd, C., Gorton, T., Symonds, E., Martin, A. & Plowright, R. (1999) The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Quality Life Research, 8, 79-91.
58. McMillan, C.V., Bradley, C., Razvi, S. & Weaver, J.U. (2005) Psychometric validation of new measures of hypothyroid-dependent quality of life (QoL) and symptoms. Endocrine Abstracts, 9, 151.
59. Indra, R., Patil, S.S., Joshi, R., Pai, M. & Kalantri, S.P. (2004) Accuracy of physical examination in the diagnosis of hypothyroidism: a cross-sectional, double blind study. Journal of Postgraduate Medicine, 50, 7-11.
60. Billewicz, W.Z., Chapman, R.S., Crooks, J., Day, M.E., Gossage, J., Wayne, E. & Young, J.A. (1969) Statistical methods applied to the diagnosis of hypothyroidism. Quarterly Journal of Medicine, 38, 255-266.
61. Philp, J.R., Duthie, M.B. & Crooks, J. (1968) A follow-up scheme for detecting hypothyroidism in thyrotoxic patients treated with radioiodine. Lancet, 2, 1336-1338.
62. Nystrom, E., Caidahl, K., Fager, G., Wikkelso, C., Lundberg, P.A. & Lindstedt, G. (1988) A double-blind cross-over 12-month study of 1-thyroxine treatment of women with 'subclinical' hypothyroidism. Clinical Endocrinology, 29, 63-75.
63. Cooper, D.S., Halpern, R., Wood, L.C., Levin, A.A. & Ridgway, E.C. (1984) L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo controlled trial. Annals of Internal Medicine, 101, 18-24.
64. Zulewski, H., Muller, B., Exer, P., Miserez, A.R. & Staub, J.J. (1997) Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. Journal of Clinical Endocrinology and Metabolism, 82, 771-776.
65. Meier, C., Staub, J.J., Roth, C.B., Guglielmetti, M., Kunz, M., Miserez, A.R., Drewe, J., Huber, P., Herzog, R. & Muller, B. (2001) TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). Journal of Clinical Endocrinology and Metabolism, 86, 4860-4866.
66. Meier, C., Trittibach, P., Guglielmetti, M., Staub, J.J. & Muller, B. (2003) Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross-sectional survey. British Medical Journal, 326, 311-312.
67. Canaris, G.J., Manowitz, N.R., Mayor, G. & Ridgway, E.C. (2000) The Colorado Thyroid Disease Prevalence Study. Archives of Internal Medicine, 160, 526-534.
68. Seshadri, M.S., Samuel, B.U., Kanagasabapathy, A.S. & Cherian, A.M. (1989) Clinical scoring system for hypothyroidism: is it useful? Journal of General Internal Medicine, 4, 490-492.
69. Barker, D.J. & Bishop, J.M. (1969) Computer-based screening system for patients at risk of hypothyroidism. Lancet, 2, 835-838.
70. Harrison, L.C., Buckley, J.D. & Martin, F.I. (1977) Use of a computer-based postal questionnaire for the detection of hypothyroidism following radioiodine therapy for thyrotoxicosis. Australian and New Zealand Journal of Medicine, 7, 27-32.
71. Wilson, I.B. & Cleary, P.D. (1995) Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. Journal of the American Medical Association, 273, 59-65.
72. Woodcock, A.J., Julious, S.A., Kinmonth, A.L. & Campbell, M.J. (2001) Problems with the performance of the SF-36 among people with type 2 diabetes in general practice. Quality of Life Research, 10, 661-670.
73. Jaeschke, R., Guyatt, G.H. & Cook, D. (1992) Quality of life instruments in the evaluation of new drugs. Pharmacoeconomics, 1, 84-94.
74. Jenkinson, C., Coulter, A. & Wright, L. (1993) Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. British Medical Journal, 306, 1437-1440.
75. Guyatt, G.H. & Jaeschke, R.J. (1997) Reassessing quality-of-life instruments in the evaluation of new drugs. Pharmacoeconomics, 12, 621-626.
76. Cook, D.J., Guyatt, G.H., Juniper, E., Griffith, L., McIlroy, W., Willan, A., Jaeschke, R. & Epstein, R. (1993) Interviewer versus self administered questionnaires in developing a disease-specific, health-related quality of life instrument for asthma. Journal of Clinical Epidemiology, 46, 529-534.
77. Bowling, A., Bond, M., Jenkinson, C. & Lamping, D.L. (1999) Short Form 36 (SF-36) Health Survey questionnaire: which normative data should be used? Comparisons between the norms provided by the Omnibus Survey in Britain, the Health Survey for England and the Oxford Healthy Life Survey. Journal of Public Health Medicine, 21, 255-270.